The investment follows the announcement of GHO Capital III, in July 2021, with over €2 billion of capital available to invest, the addition of new team hires and the opening of a US office in Research Triangle Park in support of GHO’s network of North American companies.
Against a backdrop of industry fragmentation, the company will significantly benefit from GHO’s resources, expertise and global reach in building its European practice and driving geographic expansion via M&A. Led by its founders, Rich Mynahan, Steve Chao and Kevin Richard, alongside a world-class leadership team, ClearView is well positioned to enhance its market-leading position within life sciences consulting, an industry exhibiting accelerating secular growth. ClearView services a wide range of market leading innovators across the Big Pharma/Biopharma, Diagnostics, MedTech, and life science services/tools segments. ClearView supports drug sponsors throughout the development and commercialisation process as well as guides overall approaches to clinical and commercial portfolio development. Headquartered in Boston and with offices in New York, San Francisco, London and Zurich, ClearView is known for combining its deep and diversified therapeutic expertise with business insights to deliver actionable recommendations to its customers in support of growth and innovation strategy.
LONDON & BOSTON, September 01, 2021-( BUSINESS WIRE)-Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare, and the founding partners of ClearView Healthcare Partners, announce a majority recapitalization of ClearView Healthcare Partners ("ClearView"), the leading life sciences strategic consultancy supporting Pharma and Biotech sponsors globally.
Management to pursue international markets and broaden service offering, leveraging GHO’s unparalleled sector expertise GHO received legal advice from Ropes & Gray commercial advice from Marwood financial, tax and debt advice from Deloitte LLP ESG advice from Bridgehouse Advisors and insurance advice from Hays.Ĭlearsight Advisors and Houlihan Lokey LLP served as co-strategic advisers to ClearView, while Winston & Strawn and Foley Hoag LLP served as legal counsel and RSM US LLP served as financial and tax adviser.GHO partnering with existing management team to accelerate global growthĬlearView positioned as market leader in an industry experiencing strong tailwinds office in North Carolina's Research Triangle Park to assist GHO's network of North American businesses. "We believe GHO, with its strong sector expertise, is uniquely positioned to build on ClearView’s strong track record and reputation," the GHO partners stated, "We look forward to supporting the business in driving international expansion and building out its domain expertise to deliver strategically critical insights to its Biopharma customer base.”Īdditionally, the investment follows the announcement of GHO Cash III in July 2021, which will include approximately $2,376,700,000 in available capital, additional team members and the establishment of a U.S. GHO reportedly acquired a majority stake in ClearView from RLH Equity Partners for an undisclosed amount with the firm's founding partners and leadership maintaining a significant ownership holding. "We are delighted to have the opportunity to partner with the ClearView team," GHO Capital partners stated in the press release, "Operating within a highly fragmented market, ClearView is a best-in-class consultancy within the life sciences space. We thank RLH Equity Partners for their support in contributing to ClearView’s position as a market leader in the life sciences consulting sector."ĬlearView is known for integrating its clinical knowledge with business insights to provide practical suggestions to its clients in order to help them achieve their growth and innovation goals. "We are excited to be working with GHO given their extensive healthcare expertise and experience in geographic expansion across Europe and the US," the ClearView founders stated in the press release, "We believe GHO is the right partner for ClearView as we look to new markets and drive the expansion and growth of the company to its next level.
Global Healthcare Opportunities (GHO) Capital Capital Partners LLP, a London-based healthcare specialist investor and the founding partners of ClearView Healthcare Partners recently, announced a majority recapitalization of ClearView Healthcare Partners, a life sciences strategic consulting firm supporting pharmaceutical and biotechnology sponsors, according to a press release from GHO Capital.īoston-based ClearView is led by its founders Rich Mynahan, Steve Chao and Kevin Richard.
0 kommentar(er)
